Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea

PHASE3CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Migraine Disorders
Interventions
DRUG

sumatriptan succinate/naproxen sodium

DRUG

placebo

placebo to match

Trial Locations (34)

11803

GSK Investigational Site, Plainview

12206

GSK Investigational Site, Albany

14609

GSK Investigational Site, Rochester

15236

GSK Investigational Site, Pittsburgh

27401

GSK Investigational Site, Greensboro

29651

GSK Investigational Site, Greer

30342

GSK Investigational Site, Atlanta

33173

GSK Investigational Site, Miami

33328

GSK Investigational Site, Fort Lauderdale

38018

GSK Investigational Site, Memphis

43081

GSK Investigational Site, Westerville

44131

GSK Investigational Site, Independence

44195

GSK Investigational Site, Cleveland

48201

GSK Investigational Site, Detroit

63141

GSK Investigational Site, St Louis

65804

GSK Investigational Site, Springfield

67207

GSK Investigational Site, Wichita

72205

GSK Investigational Site, Little Rock

76104

GSK Investigational Site, Fort Worth

78229

GSK Investigational Site, San Antonio

78705

GSK Investigational Site, Austin

84121

GSK Investigational Site, Salt Lake City

85201

GSK Investigational Site, Mesa

87102

GSK Investigational Site, Albuquerque

92128

GSK Investigational Site, San Diego

92660

GSK Investigational Site, Newport Beach

94102

GSK Investigational Site, San Francisco

95628

GSK Investigational Site, Fair Oaks

97401

GSK Investigational Site, Eugene

98801

GSK Investigational Site, Wenatchee

06902

GSK Investigational Site, Stamford

01757

GSK Investigational Site, Milford

02747

GSK Investigational Site, North Dartmouth

08057

GSK Investigational Site, Moorestown

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY